Donald J. Lazas Jr. MD
Advanced Endoscopic Interventional, Biliary Tract Disease, Esophagus Disease
GI @ Associates in Gastro
Join to View Full Profile
5653 Frist BlvdSuite 530Hermitage, TN 37076
Phone+1 615-885-1093
Fax+1 615-885-1110
Dr. Lazas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Capital ConsortiumFellowship, Gastroenterology, 1993 - 1995- National Capital ConsortiumResidency, Internal Medicine, 1988 - 1991
George Washington University School of Medicine and Health SciencesClass of 1988
Certifications & Licensure
TN State Medical License 1997 - 2026
FL State Medical License 2021 - 2023
GA State Medical License 1995 - 1997
MD State Medical License 1991 - 1996
Publications & Presentations
PubMed
- 7 citationsClinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis.Naim Alkhouri, Donald Lazas, Rohit Loomba, Juan P Frias, Shibao Feng
Alimentary Pharmacology & Therapeutics. 2023-11-01 - 23 citationsTropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.Quentin M Anstee, Kathryn J Lucas, Sven Francque, Manal F Abdelmalek, Arun J Sanyal
Hepatology. 2023-10-01 - 119 citationsRandomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.Rohit Loomba, Arun J Sanyal, Kris V Kowdley, Deepak L Bhatt, Naim Alkhouri
The New England Journal of Medicine. 2023-09-14
Committees
- Member, Board of Trustees, Summit Medical Center 2014 - 2014
Professional Memberships
- Fellow
- Fellow
Industry Relationships
- Founder & Managing Partner, NueCura Partners, LLCHealthcare Angel Investor Company2013 - 2014
- Chairman, Medical Advisory Council, Diatherix Laboratories, Inc.Target Enriched Multiplex PCR in infectious disease diagnosis, linking diagnostics to therapeutics.2012 - 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
